Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cornerstone Therapeutics In
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cornerstone Therapeutics Inc. Shareholders
NEW YORK--(BUSINESS WIRE)-- Kirby McInerney LLP is investigating potential claims against the Board of Directors of Cornerstone Therapeutics Inc. ("Cornerstone" or the "Company") (NAS: CRTX) related to the proposed acquisition of the Company by Chiesi Farmaceutici S.p.A. ("Chiesi"). Under the terms of the agreement, Chiesi will acquire all of the outstanding common stock of Cornerstone that it does not already own for a cash purchase price of between $6.40 and $6.70 per share.
The investigation concerns whether the Cornerstone Board of Directors is violating its fiduciary duties and whether the proposed per share consideration adequately values Cornerstone common shares.
If you are a Cornerstone shareholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at firstname.lastname@example.org, by telephone at (212) 699-1145 or (888) 529-4787, or by filling out this contact form.
Kirby McInerney LLP is a New York-based law firm concentrating in securities, shareholder, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.
Kirby McInerney LLP
J. Brandon Walker, Esq., 212-699-1145 or 888-529-4787
KEYWORDS: United States North America New York North Carolina
The article Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cornerstone Therapeutics Inc. Shareholders originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.